Advertisement

Topics

To What End? Decipher Tells Prostate Cancer Metastasis Risk

07:44 EDT 22 Jun 2017 | Medscape

The genomic test appears to add prognostic value in comparison with widely used clinicopathologic features, according to a new meta-analysis. But how should it be used?
Medscape Medical News

Original Article: To What End? Decipher Tells Prostate Cancer Metastasis Risk

NEXT ARTICLE

More From BioPortfolio on "To What End? Decipher Tells Prostate Cancer Metastasis Risk"

Advertisement
Quick Search
Advertisement
Advertisement